Faculty » Faculty Directory

Faculty Directory

Ravinder Wali
Clinical Professor of Medicine

Office Phone: 202-741-2233
Email: Email
Department: Medicine

Education

  • MBBS, Government Medical College, Kashmir, 1976
  • MD, Government Medical College, Kashmir, 1980

Biography

Ravinder K Wali, MBBS, MD, MRCP (UK):

Ravinder Wali is the Medical Director of Inova Health System’s Abdominal Transplant Program. He is a clinical Professor of Medicine at George Washington University School of Medicine and Virginia Commonwealth University School of Medicine. He is a clinical Associate Professor of Medicine at University of Maryland School of Medicine. He is an integral part of the GW nephrology fellowship program. Dr. Wali is an exceptional teacher who is valued for pragmatic educating of the young clinician-scientists that follow through clinical rotations at Inova transplant center.

Dr. Wali is a devoted clinician whose passion is to strengthen the care delivery for individuals with CKD as well as those who wish to receive, or have received, a kidney transplantation. He is the first physician-scientist who described that HIV associated nephropathy is reversible with the use of HAART which redefined the landscape of irreversible renal failure during the epidemic of HIV disease in American and in the African continent. This was further complimented with advances in offering kidney transplantation in HIV patients with sustained viral response and ESRD.

Dr. Wali furthered research into the existence of uremic cardiomyopathy. He defined the outcome of non-ischemic dilated cardiomyopathy (HFrEF) in ESRD population and its reversal with successful kidney transplantation. This work fundamentally changed the art of delivering care to patients with ESRD who were previously deemed unfit to undergo transplantation. He is determined to change the trajectory of ASCVD in patients with ESRD, and in patients following transplantation.

He also pioneered an innovative approach for the management and treatment of polyoma viral disease after organ transplantation. His astute clinical research allowed the development of rescue therapy with the use of mTOR-i in those with progressive polyoma viral disease who failed to respond to conventional therapy and are at risk of graft failure.

Dr. Wali was selected as a KOL by American Transplant Society to define the pathways to prevent the development of kidney allograft dysfunction and rescue therapy to prevent/delay the development of graft failure in patients with threatened allograft.

He has dedicated his work and clinical skills in expanding kidney transplant program for high risk ESRD patients who blood group incompatible donors, highly sensitized recipients, as well as patients with HIV.

Division

  • Renal Diseases and Hypertension

Publications

View publications by this faculty member.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.

  • None